| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Nibaldo C Inestrosa | |
| Alejandra Alvarez | |||
| Margarita C Dinamarca | |||
| P2860 | cites work | The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation | Q46654832 |
| Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease | Q47683833 | ||
| Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles | Q48176447 | ||
| Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus | Q48200399 | ||
| Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains | Q48352514 | ||
| Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein | Q48518447 | ||
| Butyrylcholinesterase in the life cycle of amyloid plaques | Q48582974 | ||
| Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice. | Q48839189 | ||
| Spatial pattern of prion protein deposits in patients with sporadic Creutzfeldt-Jakob disease | Q48916074 | ||
| Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. | Q49047282 | ||
| Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. | Q53189225 | ||
| Abnormalities of acetylcholinesterase in Alzheimer's disease with special reference to effect of acetylcholinesterase inhibitor. | Q53216454 | ||
| Molecular interactions of acetylcholinesterase with senile plaques. | Q53224790 | ||
| Acetylcholinesterase triggers the aggregation of PrP 106-126 | Q57217215 | ||
| Effect of acetylcholinesterase inhibitors on AChE-induced PrP106-126 aggregation | Q57217497 | ||
| Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica | Q57998530 | ||
| Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation | Q27643075 | ||
| Structural roles of acetylcholinesterase variants in biology and pathology | Q33734605 | ||
| Butyrylcholinesterase attenuates amyloid fibril formation in vitro | Q34695275 | ||
| Deciphering the molecular basis of memory failure in Alzheimer's disease | Q35902501 | ||
| Molecular modelling approaches to the design of acetylcholinesterase inhibitors: new challenges for the treatment of Alzheimer's disease | Q35950173 | ||
| Structure and function of amyloid in Alzheimer's disease | Q36008911 | ||
| Interaction of partially unfolded forms of Torpedo acetylcholinesterase with liposomes | Q36279465 | ||
| Role of copper in prion diseases: deleterious or beneficial? | Q36536420 | ||
| A hundred years of Alzheimer's disease research | Q36610336 | ||
| Fibrillogenesis of synthetic amyloid-beta peptides is dependent on their initial secondary structure | Q36797300 | ||
| Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. | Q36885421 | ||
| Comparison of butyrylcholinesterase and acetylcholinesterase | Q38677133 | ||
| Distribution and anchoring of molecular forms of acetylcholinesterase | Q38727810 | ||
| Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics | Q40097329 | ||
| Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease | Q40352789 | ||
| Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease | Q40779689 | ||
| Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins | Q41550219 | ||
| Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease | Q41849847 | ||
| Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease | Q43734690 | ||
| beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies | Q44277892 | ||
| 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy | Q44457429 | ||
| Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues | Q45146566 | ||
| Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors | Q46263827 | ||
| Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation | Q46563195 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 625-632 | |
| P577 | publication date | 2008-01-17 | |
| P1433 | published in | FEBS Journal | Q1388041 |
| P1476 | title | Amyloid-cholinesterase interactions. Implications for Alzheimer's disease | |
| P478 | volume | 275 |
| Q50705887 | 6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease. |
| Q50545970 | 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease. |
| Q35874432 | 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment. |
| Q40644631 | Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior. |
| Q41813709 | Amyloid-beta-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's disease |
| Q90220831 | Anticholinesterase and Antioxidant Activity of New Binary Conjugates of γ-Carbolines |
| Q39438767 | Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs |
| Q35792386 | Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction |
| Q43069725 | Baculovirus expression, biochemical characterization and organophosphate sensitivity of rBmAChE1, rBmAChE2, and rBmAChE3 of Rhipicephalus (Boophilus) microplus |
| Q43058871 | Bis(7)-tacrine derivatives as multitarget-directed ligands: Focus on anticholinesterase and antiamyloid activities |
| Q34422385 | Cellular and molecular actions of Methylene Blue in the nervous system |
| Q35060833 | Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease |
| Q91962778 | Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones |
| Q101403238 | Clustering of Alzheimer's and Parkinson's disease based on genetic burden of shared molecular mechanisms |
| Q64077918 | Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases |
| Q41838573 | Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors |
| Q42949667 | Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors |
| Q39613009 | Dramatic increase in readthrough acetylcholinesterase in a cellular model of oxidative stress |
| Q39022532 | Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends |
| Q64253164 | Dual BACE1 and Cholinesterase Inhibitory Effects of Phlorotannins from -An In Vitro and in Silico Study |
| Q52355116 | Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer's Disease Drug Discovery. |
| Q50744649 | Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors. |
| Q90340437 | GAPT regulates cholinergic dysfunction and oxidative stress in the brains of learning and memory impairment mice induced by scopolamine |
| Q92649227 | Homomeric and Heteromeric Aβ Species Exist in Human Brain and CSF Regardless of Alzheimer's Disease Status and Risk Genotype |
| Q47218668 | Hot Spots for Protein Partnerships at the Surface of Cholinesterases and Related α/β Hydrolase Fold Proteins or Domains-A Structural Perspective |
| Q34797526 | Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model |
| Q27675368 | Huprine derivatives as sub-nanomolar human acetylcholinesterase inhibitors: from rational design to validation by X-ray crystallography |
| Q84969941 | Hyperbolic mixed-type inhibition of acetylcholinesterase by tetracyclic thienopyrimidines |
| Q94450853 | In vitro enzyme inhibitory and cytotoxic studies with Evolvulus alsinoides (Linn.) Linn. Leaf extract: a plant from Ayurveda recognized as Dasapushpam for the management of Alzheimer's disease and diabetes mellitus |
| Q37261432 | Inclusion body myositis: a view from the Caenorhabditis elegans muscle |
| Q64238656 | Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability |
| Q35247531 | Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases. |
| Q21129335 | Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706 |
| Q28077589 | Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration |
| Q48881941 | Metrifonate alters antioxidant levels and caspase activity in cerebral cortex of Wistar rats |
| Q53333065 | Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors. |
| Q91994595 | Multi-Target β-Protease Inhibitors from Andrographis paniculata: In Silico and In Vitro Studies |
| Q97886269 | Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations |
| Q38132755 | Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors? |
| Q46606963 | Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer's Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway |
| Q46833725 | Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer's Disease |
| Q58599100 | Neuroprotective effects of matrine on scopolamine-induced amnesia via inhibition of AChE/BuChE and oxidative stress |
| Q46373925 | Non-enzymatic developmental functions of acetylcholinesterase--the question of redundancy |
| Q38451615 | Non-synaptic roles of acetylcholinesterase and agrin. |
| Q99548785 | Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease |
| Q35918929 | Novel Triazole-Quinoline Derivatives as Selective Dual Binding Site Acetylcholinesterase Inhibitors. |
| Q33699095 | Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates |
| Q39848491 | Novel piperazine derivative PMS1339 exhibits tri-functional properties and cognitive improvement in mice |
| Q35210180 | Revisiting the Role of Acetylcholinesterase in Alzheimer's Disease: Cross-Talk with P-tau and β-Amyloid |
| Q91826157 | Silymarin's Inhibition and Treatment Effects for Alzheimer's Disease |
| Q50857626 | Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta. |
| Q34564278 | The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies. |
| Q43989406 | The neuroligins and their ligands: from structure to function at the synapse. |
| Q57300454 | Therapy of Dredging the Bowels Enhanced the Neuroprotective Effect of Nourishing Kidney Herbs on Hippocampal Cholinergic System in Alzheimer's Disease Model Rat Induced by A 1-42 |
| Q47099682 | Troxerutin protects hippocampal neurons against amyloid beta-induced oxidative stress and apoptosis |
| Q33418312 | Upregulation of alpha7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides |
Search more.